16.37
Hercules Capital Inc stock is traded at $16.37, with a volume of 877.67K.
It is down -1.74% in the last 24 hours and down -6.83% over the past month.
Hercules Capital Inc is a specialty finance company focused on providing senior secured loans to high-growth, venture capital-backed, and institutional-backed companies in a variety of technology and life sciences industries. The company's primary business objectives are to increase its net income, net investment income, and net asset value (NAV) through its investments mainly in structured debt or senior secured debt instruments of venture capital-backed and institutional-backed companies across a variety of technology-related industries at attractive yields. It finances companies belonging to computer software and hardware, networking systems, semiconductors, medical devices, bio-pharmaceutical, and other related sectors.
See More
Previous Close:
$16.66
Open:
$16.67
24h Volume:
877.67K
Relative Volume:
0.85
Market Cap:
$3.06B
Revenue:
$514.85M
Net Income/Loss:
$328.86M
P/E Ratio:
9.2194
EPS:
1.7756
Net Cash Flow:
$311.25M
1W Performance:
-0.85%
1M Performance:
-6.83%
6M Performance:
+4.67%
1Y Performance:
-4.60%
Hercules Capital Inc Stock (HTGC) Company Profile
Name
Hercules Capital Inc
Sector
Industry
Phone
650-289-3060
Address
1 NORTH B STREET, SAN MATEO, CA
Compare HTGC vs BLK, BX, BN, KKR, BAM
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
|
HTGC
Hercules Capital Inc
|
16.37 | 3.06B | 514.85M | 328.86M | 311.25M | 1.7756 |
|
BLK
Blackrock Inc
|
1,134.38 | 175.68B | 27.61B | 7.13B | 3.76B | 40.76 |
|
BX
Blackstone Inc
|
106.61 | 85.07B | 16.59B | 6.83B | 869.79M | 4.4576 |
|
BN
Brookfield Corp
|
36.62 | 81.75B | 77.61B | 4.06B | -8.36B | 0.497 |
|
KKR
Kroger Co
|
86.21 | 77.39B | 22.38B | 5.74B | 8.54B | 2.9339 |
|
BAM
Brookfield Asset Management Ltd
|
45.32 | 72.39B | 5.07B | 2.48B | 2.37B | 1.5532 |
Hercules Capital Inc Stock (HTGC) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Sep-01-26 | Upgrade | UBS | Neutral → Buy |
| Feb-13-26 | Downgrade | Piper Sandler | Overweight → Neutral |
| Nov-04-25 | Upgrade | Compass Point | Neutral → Buy |
| Dec-12-24 | Upgrade | Keefe Bruyette | Mkt Perform → Outperform |
| Jan-16-24 | Downgrade | Compass Point | Buy → Neutral |
| Nov-21-23 | Initiated | UBS | Neutral |
| Aug-30-23 | Upgrade | Compass Point | Neutral → Buy |
| Aug-04-23 | Upgrade | Keefe Bruyette | Underperform → Mkt Perform |
| Apr-06-23 | Upgrade | Piper Sandler | Neutral → Overweight |
| Mar-13-23 | Downgrade | Keefe Bruyette | Mkt Perform → Underperform |
| Jul-29-22 | Downgrade | Oppenheimer | Outperform → Perform |
| Apr-22-22 | Downgrade | Keefe Bruyette | Outperform → Mkt Perform |
| Apr-04-22 | Downgrade | Piper Sandler | Overweight → Neutral |
| Feb-08-22 | Downgrade | Compass Point | Buy → Neutral |
| Apr-28-21 | Initiated | Oppenheimer | Outperform |
| Mar-25-21 | Initiated | RBC Capital Mkts | Outperform |
| Nov-02-20 | Resumed | JMP Securities | Mkt Outperform |
| Jul-31-20 | Upgrade | Compass Point | Neutral → Buy |
| Jul-20-20 | Resumed | Piper Sandler | Overweight |
| Jun-19-20 | Upgrade | Janney | Neutral → Buy |
| Mar-31-20 | Upgrade | Keefe Bruyette | Mkt Perform → Outperform |
| Nov-04-19 | Upgrade | Wells Fargo | Market Perform → Outperform |
| May-06-19 | Downgrade | Wells Fargo | Outperform → Market Perform |
| May-03-19 | Upgrade | B. Riley FBR | Neutral → Buy |
| Mar-13-19 | Downgrade | B. Riley FBR | Buy → Neutral |
| Mar-13-19 | Downgrade | Keefe Bruyette | Outperform → Mkt Perform |
| Feb-07-18 | Upgrade | Wedbush | Neutral → Outperform |
| Feb-06-18 | Upgrade | Sandler O'Neill | Hold → Buy |
| Nov-20-17 | Initiated | Ladenburg Thalmann | Buy |
| Nov-03-17 | Upgrade | Raymond James | Underperform → Mkt Perform |
| Oct-25-17 | Initiated | Wedbush | Neutral |
| Oct-02-17 | Resumed | FBR & Co. | Buy |
| Sep-08-17 | Upgrade | Compass Point | Neutral → Buy |
| Aug-07-17 | Resumed | JMP Securities | Mkt Outperform |
| Aug-04-17 | Downgrade | Raymond James | Mkt Perform → Underperform |
| Feb-24-17 | Reiterated | FBR & Co. | Outperform |
View All
Hercules Capital Inc Stock (HTGC) Latest News
Hercules Capital Receives Affirmed BBB- Investment Grade Corporate and Unsecured Credit Rating from Fitch Ratings, Inc. - Business Wire
Hercules Capital (HTGC) Exceeds Market Returns: Some Facts to Consider - Zacks Investment Research
Hercules Capital (HTGC) Exceeds Market Returns: Some Facts to Consider - Yahoo Finance Singapore
Hercules Capital, Inc. (HTGC) stock price, news, quote and history - Yahoo Finance Singapore
Hercules Capital Announces Date for Release of Third Quarter 2026 Financial Results and Conference Call - Moomoo
Hercules Capital Announces Date for Release of Third Quarter 2026 Financial Results and Conference Call - Business Wire
HERCULES CAPITAL INC 6.25% NOTES DUE 2033 USD25 To Go Ex-Dividend On October 15th, 2026 With 0.39063 USD Dividend Per Share - Moomoo
Form 4 Hercules Capital Inc: Seth H. Meyer (President) For: 9 October - Investing.com Nigeria
Vesting taxes prompted withholding of 6,469 shares from Hercules Capital (HCXY) President Seth H. Meyer. - Stock Titan
At $16.51 a share, Hercules Capital (HCXY) withholds stock for CEO Scott Bluestein's vesting taxes. - Stock Titan
Tax withholding at Hercules Capital (HCXY) covers 1,974 shares at $16.51 each. - Stock Titan
Tax withholding covers 1,365 and 1,433 shares for Hercules Capital (HCXY) COO Christian Follmann. - Stock Titan
Hercules Capital: Rate Hike Could Bring The Costs Without The Income; Downgrade To Sell - Seeking Alpha
Hercules Capital, Inc. (0J4M.L) stock price, news, quote and history - Yahoo Finance UK
Hercules Capital (HTGC) Advances While Market Declines: Some Information for Investors - Zacks Investment Research
Hercules Capital (HTGC) Advances While Market Declines: Some Information for Investors - Yahoo Finance
Hercules Capital Closes Upsized $400 Million Notes Offering - Yahoo Finance
Hercules Capital Issues $400 Million 6.700% Senior Notes Due 2029 to Refinance Debt - TradingView
Hercules Capital Closes Institutional Notes Offering of $400.0 Million 6.700% Notes due 2029 - Business Wire
Hercules Capital stock hits 52-week low at 24.14 USD - Investing.com
Cranbury biotech Rocket Pharmaceuticals lands credit facility for up to $150M from Hercules Capital - ROI-NJ
Latham & Watkins Advises on Rocket Pharmaceuticals’ Growth Facility - Latham & Watkins LLP
Trading the Move, Not the Narrative: (HCXY) Edition - Stock Traders Daily
Rocket Pharmaceuticals Secures $150M Senior Secured Term Loan with Hercules Capital, Issues Warrants - Kalkine Media
Rocket Pharmaceuticals secures $150M credit facility with Hercules Capital - StreetInsider
Rocket Pharmaceuticals Secures Strategic Credit Facility for Up to $150 Million from Hercules Capital - Business Wire
Hercules Capital prices $400 million notes offering at 6.70% - Investing.com
Hercules Capital Prices $400 Million Note Offering Due 2029 - marketscreener.com
Hercules Capital prices upsized $400M notes offering due 2029 - TradingView
Hercules Capital prices $400M notes offering at 6.70% due 2029 - StreetInsider
Hercules Capital Prices Upsized Institutional Notes Offering of $400.0 Million 6.70% Notes due 2029 - Business Wire
Hercules Capital Prices Upsized Institutional Notes Offering of $400.0 Million 6.70% Notes due 2029 - Yahoo Finance
Hercules Capital (HTGC) Stock Sinks As Market Gains: Here's Why - Yahoo Finance
Hercules Capital (HTGC) Stock Sinks As Market Gains: Here's Why - Zacks Investment Research
Hercules Capital (HTGC) Stock May Still Be A Bargain On Equity Returns - Yahoo Finance
2 Reasons HTGC is Risky and 1 Stock to Buy Instead - Yahoo Finance
Net income of Hercules Capital, Inc. – HAN:19H - TradingView
Is Hercules Capital (HTGC) Undervalued As Its Board Adds A New Audit Director? - Yahoo Finance
Hercules Capital Signs $185 Million Growth Capital Facility With NorthStar Medical Technologies - marketscreener.com
Hercules Capital Signs $185 Million Growth Capital Facility With NorthStar Medical Technologies - Yahoo Finance
NorthStar Secures Up to $185 Million Growth Financing Led by Hercules Capital to Scale Actinium-225 Production and Radiopharmaceutical Manufacturing for Next-Generation Precision Cancer Therapies - Business Wire
Hercules Capital, Inc. (HTGC) Stock Price, News, Quote & History - ca.finance.yahoo.com
Is It Worth Investing in Hercules Capital (HTGC) Based on Wall Street's Bullish Views? - finance.yahoo.com
Is It Worth Investing in Hercules Capital (HTGC) Based on Wall Street's Bullish Views? - Eastern Progress
Hercules Capital (HTGC) Dips More Than Broader Market: What You Should Know - Yahoo Finance UK
Hercules Capital (HTGC) Dips More Than Broader Market: What You Should Know - Yahoo Finance
Here's Why Hercules Capital (HTGC) Fell More Than Broader Market - Zacks Investment Research
Here's Why Hercules Capital (HTGC) Fell More Than Broader Market - finance.yahoo.com
Hercules Capital, Inc. (HTGC) stock price, news, quote and history - Yahoo Finance UK
Why Is Hercules Capital (NYSE:HTGC) Q2 Activity Drawing Focus? - Kalkine Media
Hercules Capital Inc Stock (HTGC) Financials Data
Revenue
Net Income
Cash Flow
EPS
Hercules Capital Inc Stock (HTGC) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| Randhawa Paramjeet K | Director |
Mar 26 '26 |
Buy |
14.35 |
2,926 |
41,988 |
22,486 |
| Fallon Thomas J | Director |
Mar 26 '26 |
Buy |
14.30 |
7,300 |
104,390 |
157,669 |
| Aguirre DeAnne | Director |
Mar 26 '26 |
Buy |
14.35 |
7,317 |
104,999 |
10,749 |
| Loo Wade | Director |
Mar 26 '26 |
Buy |
14.35 |
7,317 |
104,999 |
14,050 |
| CROWELL GAYLE A | Director |
Mar 26 '26 |
Buy |
14.35 |
7,317 |
104,999 |
97,589 |
| Theodosopoulos Nikos | Director |
Mar 26 '26 |
Buy |
14.35 |
7,317 |
104,999 |
29,362 |
| Randhawa Paramjeet K | Director |
Mar 04 '26 |
Buy |
14.78 |
3,050 |
45,079 |
19,560 |
| Botelho Kiersten Zaza | Chief Legal Officer & CCO |
Feb 27 '26 |
Buy |
14.21 |
1,300 |
18,473 |
93,336 |
| Theodosopoulos Nikos | Director |
Feb 27 '26 |
Buy |
14.21 |
2,600 |
36,946 |
21,523 |
| BADAVAS ROBERT P | Director |
Feb 27 '26 |
Buy |
14.27 |
5,000 |
71,350 |
122,073 |
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):